Journal
FATIGUE-BIOMEDICINE HEALTH AND BEHAVIOR
Volume 9, Issue 1, Pages 9-13Publisher
ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.1080/21641846.2021.1878716
Keywords
Myalgic encephalomyelitis; chronic fatigue syndrome; prevalence; economic impact
Categories
Ask authors/readers for more resources
According to the latest data, there has been a significant increase in the prevalence and economic impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in the United States, with approximately 1.5 million people affected and an economic impact ranging from 36 to 51 billion dollars annually.
We update the US prevalence and economic impact estimates of the 2015 National Academy of Medicine report on myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS), taking into account growth in population, economic inflation, and inclusion of children. We find a rough doubling of the ME/CFS prevalence and economic impact figures in the US, with low-end prevalence coming out to 1.5 million and economic impact having a range of 36-51 billion dollars per year.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available